SlideShare une entreprise Scribd logo
1  sur  1
Télécharger pour lire hors ligne
Patient Global Assessment of Disease Activity
Considering all the ways your arthritis affects you, rate how well you are doing on the following scale:
Very
Well
                     Very
Poor0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10
Your Name_____________________________________ Date of Birth ____________ Today’s Date ______________
Provider Global Assessment of Disease Activity
Very
Well
                     Very
Poor0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10
How to Score the CDAI
Variable Range Value CDAI Score Interpretation
Tender joint score (0-28) 0.0 – 2.8 Remission
Swollen joint score (0-28) 2.9 – 10.0 Low Activity
Patient global score (0-10) 10.1 – 22.0 Moderate Activity
Provider global score (0-10) 22.1 – 76.0 High Activity
Add the above values to
calculate the CDAI score
(0-76)
Clinical Disease Activity Index (CDAI)
Joint Left Right
Tender Swollen Tender Swollen
Shoulder
Elbow
Wrist
MCP 1
MCP 2
MCP 3
MCP 4
MCP 5
PIP 1
PIP 2
PIP 3
PIP 4
PIP 5
Knee
Total Tender: Swollen:

Contenu connexe

Tendances

History taking upper gastro intestinal bleeding
History taking upper gastro intestinal bleedingHistory taking upper gastro intestinal bleeding
History taking upper gastro intestinal bleeding
Abino David
 
Polymyalgia rheumatica
Polymyalgia rheumaticaPolymyalgia rheumatica
Polymyalgia rheumatica
ZaynZafar2
 
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
Ahmed Albeyaly
 
Rheumatological examination
Rheumatological examinationRheumatological examination
Rheumatological examination
Ashraf Okba
 
polymyalgia rheumatica
polymyalgia rheumaticapolymyalgia rheumatica
polymyalgia rheumatica
drmomusa
 
Pediatric Rheumatic Diseases by JJ Laspoñas
Pediatric Rheumatic Diseases by JJ LaspoñasPediatric Rheumatic Diseases by JJ Laspoñas
Pediatric Rheumatic Diseases by JJ Laspoñas
JJLasponas
 

Tendances (20)

Fibromyalgia
 Fibromyalgia Fibromyalgia
Fibromyalgia
 
Non Alcoholic Fatty Liver Disease
Non Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty Liver Disease
Non Alcoholic Fatty Liver Disease
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
IBS-SIBO
IBS-SIBOIBS-SIBO
IBS-SIBO
 
5. a case study on rheumatoid arthritis
5. a case study on rheumatoid arthritis5. a case study on rheumatoid arthritis
5. a case study on rheumatoid arthritis
 
Approach to the patient with arthritis
Approach to the patient with arthritisApproach to the patient with arthritis
Approach to the patient with arthritis
 
History taking upper gastro intestinal bleeding
History taking upper gastro intestinal bleedingHistory taking upper gastro intestinal bleeding
History taking upper gastro intestinal bleeding
 
Polymyalgia rheumatica
Polymyalgia rheumaticaPolymyalgia rheumatica
Polymyalgia rheumatica
 
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
 
Case presentation on RA
Case presentation on RACase presentation on RA
Case presentation on RA
 
Rheumatological examination
Rheumatological examinationRheumatological examination
Rheumatological examination
 
Lupus nephritis 2012
Lupus nephritis 2012Lupus nephritis 2012
Lupus nephritis 2012
 
Functional dyspepsia-Approach
Functional dyspepsia-ApproachFunctional dyspepsia-Approach
Functional dyspepsia-Approach
 
Lupus Nephritis Guideline Review 2022
Lupus Nephritis Guideline Review 2022Lupus Nephritis Guideline Review 2022
Lupus Nephritis Guideline Review 2022
 
Uremic gastritis - CASE PRESENTATION
Uremic gastritis - CASE PRESENTATIONUremic gastritis - CASE PRESENTATION
Uremic gastritis - CASE PRESENTATION
 
Approach to diagnosis of arthritis
Approach to diagnosis of arthritis Approach to diagnosis of arthritis
Approach to diagnosis of arthritis
 
polymyalgia rheumatica
polymyalgia rheumaticapolymyalgia rheumatica
polymyalgia rheumatica
 
Pediatric Rheumatic Diseases by JJ Laspoñas
Pediatric Rheumatic Diseases by JJ LaspoñasPediatric Rheumatic Diseases by JJ Laspoñas
Pediatric Rheumatic Diseases by JJ Laspoñas
 
Rheumatoid Arthritis: Early Diagnosis and Treatment
Rheumatoid Arthritis: Early Diagnosis and TreatmentRheumatoid Arthritis: Early Diagnosis and Treatment
Rheumatoid Arthritis: Early Diagnosis and Treatment
 

Similaire à Cdai

4_Medicare and caid_payment_valuation
4_Medicare and caid_payment_valuation4_Medicare and caid_payment_valuation
4_Medicare and caid_payment_valuation
Michael Aponte | MHA
 
PR 10-2BCalculations.docx
PR 10-2BCalculations.docxPR 10-2BCalculations.docx
PR 10-2BCalculations.docx
ChantellPantoja184
 
Program Management
Program ManagementProgram Management
Program Management
Dan Junkins
 
Executive MPH Program PBHL 600ES – Health Management a.docx
Executive MPH Program   PBHL 600ES – Health Management a.docxExecutive MPH Program   PBHL 600ES – Health Management a.docx
Executive MPH Program PBHL 600ES – Health Management a.docx
SANSKAR20
 

Similaire à Cdai (20)

Icd 10 implementation and business final slideshare
Icd 10 implementation and business final slideshareIcd 10 implementation and business final slideshare
Icd 10 implementation and business final slideshare
 
Quotemonster roadshow session two June 2019
Quotemonster roadshow session two June 2019Quotemonster roadshow session two June 2019
Quotemonster roadshow session two June 2019
 
Research and Advicemonster Deep Dive - July 2019: Session Two
Research and Advicemonster Deep Dive - July 2019: Session TwoResearch and Advicemonster Deep Dive - July 2019: Session Two
Research and Advicemonster Deep Dive - July 2019: Session Two
 
2016 11 21 neo company overview presentation
2016 11 21   neo company overview presentation2016 11 21   neo company overview presentation
2016 11 21 neo company overview presentation
 
daewoong pharmaceutical 069620 Algorithm Investment Report
daewoong pharmaceutical 069620 Algorithm Investment Reportdaewoong pharmaceutical 069620 Algorithm Investment Report
daewoong pharmaceutical 069620 Algorithm Investment Report
 
The Middle East Consumer Confidence Index- November 2012
The Middle East Consumer Confidence Index- November 2012The Middle East Consumer Confidence Index- November 2012
The Middle East Consumer Confidence Index- November 2012
 
The ICD-10 Change-Over: Looking Ahead
The ICD-10 Change-Over: Looking AheadThe ICD-10 Change-Over: Looking Ahead
The ICD-10 Change-Over: Looking Ahead
 
Green_UHI_2022_PPT_Ch06.pptx
Green_UHI_2022_PPT_Ch06.pptxGreen_UHI_2022_PPT_Ch06.pptx
Green_UHI_2022_PPT_Ch06.pptx
 
PresentationIIP
PresentationIIPPresentationIIP
PresentationIIP
 
4_Medicare and caid_payment_valuation
4_Medicare and caid_payment_valuation4_Medicare and caid_payment_valuation
4_Medicare and caid_payment_valuation
 
2012 to 2013 Australian Hospital Digital Scanning Survey
2012 to 2013 Australian Hospital Digital Scanning Survey2012 to 2013 Australian Hospital Digital Scanning Survey
2012 to 2013 Australian Hospital Digital Scanning Survey
 
Quality Control PowerPoint Presentation Slides
Quality Control PowerPoint Presentation Slides Quality Control PowerPoint Presentation Slides
Quality Control PowerPoint Presentation Slides
 
Online Catering Services
Online Catering ServicesOnline Catering Services
Online Catering Services
 
PR 10-2BCalculations.docx
PR 10-2BCalculations.docxPR 10-2BCalculations.docx
PR 10-2BCalculations.docx
 
Escape Velocity
Escape VelocityEscape Velocity
Escape Velocity
 
Pharmacy Services Sector
Pharmacy Services SectorPharmacy Services Sector
Pharmacy Services Sector
 
August 2015 Medical Coding Q&A Webinar
August 2015 Medical Coding Q&A WebinarAugust 2015 Medical Coding Q&A Webinar
August 2015 Medical Coding Q&A Webinar
 
Hospital Readmissions Reduction Program: Keys to Success
Hospital Readmissions Reduction Program: Keys to SuccessHospital Readmissions Reduction Program: Keys to Success
Hospital Readmissions Reduction Program: Keys to Success
 
Program Management
Program ManagementProgram Management
Program Management
 
Executive MPH Program PBHL 600ES – Health Management a.docx
Executive MPH Program   PBHL 600ES – Health Management a.docxExecutive MPH Program   PBHL 600ES – Health Management a.docx
Executive MPH Program PBHL 600ES – Health Management a.docx
 

Cdai

  • 1. Patient Global Assessment of Disease Activity Considering all the ways your arthritis affects you, rate how well you are doing on the following scale: Very Well                      Very Poor0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10 Your Name_____________________________________ Date of Birth ____________ Today’s Date ______________ Provider Global Assessment of Disease Activity Very Well                      Very Poor0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10 How to Score the CDAI Variable Range Value CDAI Score Interpretation Tender joint score (0-28) 0.0 – 2.8 Remission Swollen joint score (0-28) 2.9 – 10.0 Low Activity Patient global score (0-10) 10.1 – 22.0 Moderate Activity Provider global score (0-10) 22.1 – 76.0 High Activity Add the above values to calculate the CDAI score (0-76) Clinical Disease Activity Index (CDAI) Joint Left Right Tender Swollen Tender Swollen Shoulder Elbow Wrist MCP 1 MCP 2 MCP 3 MCP 4 MCP 5 PIP 1 PIP 2 PIP 3 PIP 4 PIP 5 Knee Total Tender: Swollen: